The HDAC1 Knockout HEK293T Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human embryonic kidney HEK293T cell line, featuring targeted disruption of the HDAC1 gene. This heterogeneous cell pool offers a loss-of-function model for investigating HDAC1-dependent processes without the clonal biases inherent to single-cell-derived lines, enabling robust and reproducible functional studies.
The parental HEK293T cells are a widely utilized host for transient protein expression and viral production, owing to their stable expression of the SV40 large T-antigen. This antigen facilitates episomal replication of plasmids harboring the SV40 origin of replication, resulting in elevated transgene expression. The cells retain epithelial morphology and are amenable to standard transfection and culture protocols, making them a versatile chassis for genetic perturbation.
HDAC1 encodes a class I histone deacetylase that catalyzes the removal of acetyl groups from lysine residues on histones H3 and H4, promoting chromatin compaction and transcriptional silencing. Beyond histones, HDAC1 deacetylates key non-histone substrates including p53, E2F1, STAT3, and NF-??B, thereby modulating their transcriptional activities and impacting cell cycle arrest, apoptosis, and differentiation. Its activity is regulated by phosphorylation through casein kinase 2 (CK2) and protein kinase A (PKA), and it functions within multi-subunit corepressor complexes such as SIN3A, NuRD (containing MTA1/2, RBBP4/7, CHD4), and CoREST. In signaling networks, HDAC1 participates in Notch (NOTCH1-RBPJ-HES1), Wnt (CTNNB1-TCF7L2), TGF-?? (SMAD3), and p53 (TP53-CDKN1A) pathways, where it represses transcription of target genes to control development and homeostasis.
In the HEK293T background, disruption of HDAC1 provides a powerful tool to dissect its role in transcriptional regulation and chromatin dynamics within a system that supports high-level expression of recombinant factors. The presence of SV40 large T-antigen, which binds and inactivates p53 and Rb family members, offers a unique context for evaluating HDAC1-mediated effects on cell cycle and apoptosis pathways that intersect with these tumor suppressors. This model facilitates the study of how HDAC1 loss alters histone acetylation landscapes and downstream gene expression programs, particularly those governed by p53, E2F, and NF-??B.
Researchers can employ this knockout population in a broad array of assays: Western blotting to confirm HDAC1 depletion and changes in acetylated histones; HDAC activity assays; ChIP-qPCR for histone acetylation marks at target gene promoters; RT-qPCR for downstream targets such as CDKN1A; immunofluorescence to assess HDAC1 localization; co-immunoprecipitation to study HDAC1-containing complexes; and flow cytometry for cell cycle and apoptosis profiling. Applications span epigenetic regulation, chromatin remodeling, cancer biology, drug target validation, and HDAC inhibitor screening. For further details, please contact Ascent Research.
